131 related articles for article (PubMed ID: 32795678)
1. Impaired physical function and evaluation of quality of life in normocalcemic and hypercalcemic primary hyperparathyroidism.
Voss L; Nóbrega M; Bandeira L; Griz L; Rocha-Filho PAS; Bandeira F
Bone; 2020 Dec; 141():115583. PubMed ID: 32795678
[TBL] [Abstract][Full Text] [Related]
2. Normocalcemic primary hyperparathyroidism is an early stage of primary hyperparathyroidism according to fibroblast growth factor 23 level.
Chertok Shacham E; Maman N; Lazareva T; Masalha R; Mahagna L; Sela G; Ishay A
Front Endocrinol (Lausanne); 2023; 14():1152464. PubMed ID: 37065752
[TBL] [Abstract][Full Text] [Related]
3. Biochemical characteristics and clinical manifestation of normocalcemic primary hyperparathyroidism.
Yankova I; Lilova L; Petrova D; Dimitrova I; Stoynova M; Shinkov A; Kovatcheva R
Endocrine; 2024 Mar; ():. PubMed ID: 38489132
[TBL] [Abstract][Full Text] [Related]
4. Parathyroidectomy for Normocalcemic Primary Hyperparathyroidism is Associated with Improved Bone Mineral Density Regardless of Postoperative Parathyroid Hormone Levels.
Lui MS; Clemente-Gutierrez U; Vodopivec DM; Chang SL; Shirali AS; Huang BL; Chiang YJ; Fisher SB; Grubbs EG; Guise TA; Graham PH; Perrier ND
World J Surg; 2023 Feb; 47(2):363-370. PubMed ID: 36195677
[TBL] [Abstract][Full Text] [Related]
5. Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population.
Pierreux J; Bravenboer B
Horm Metab Res; 2018 Nov; 50(11):797-802. PubMed ID: 30396209
[TBL] [Abstract][Full Text] [Related]
6. Normocalcemic Hyperparathyroidism.
Corbetta S
Front Horm Res; 2019; 51():23-39. PubMed ID: 30641527
[TBL] [Abstract][Full Text] [Related]
7. Comparison of normocalcemic versus hypercalcemic primary hyperparathyroidism in a hypercalciuric renal stone population.
Halimi C; Bor C; Chieze R; Saint-Jacques C; Périé S; Wagner I; Talbot JN; Montravers F; Letavernier E; Buob D; Daudon M; Frochot V; Haymann JP
J Clin Endocrinol Metab; 2024 Mar; ():. PubMed ID: 38497124
[TBL] [Abstract][Full Text] [Related]
8. High Rate of Occult Urolithiasis in Normocalcemic Primary Hyperparathyroidism.
Lemos ALP; Andrade SRL; Pontes LLH; Teixeira PMC; Bandeira E; Bandeira LC; Bandeira F
Kidney Blood Press Res; 2019; 44(5):1189-1195. PubMed ID: 31542783
[TBL] [Abstract][Full Text] [Related]
9. Normocalcemic Hyperparathyroidism: Study of its Prevalence and Natural History.
Schini M; Jacques RM; Oakes E; Peel NFA; Walsh JS; Eastell R
J Clin Endocrinol Metab; 2020 Apr; 105(4):e1171-86. PubMed ID: 32072184
[TBL] [Abstract][Full Text] [Related]
10. Comparisons Between Normocalcemic Primary Hyperparathyroidism and Typical Primary Hyperparathyroidism.
Choi HR; Choi SH; Hong N; Rhee Y; Kim JK; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
J Korean Med Sci; 2022 Apr; 37(13):e99. PubMed ID: 35380024
[TBL] [Abstract][Full Text] [Related]
11. Genetic aspects underlying the normocalcemic and hypercalcemic phenotypes of primary hyperparathyroidism.
Viviani A; Colangelo L; Ciminelli BM; Novelletto A; Sonato C; Occhiuto M; Cipriani C; Diacinti D; De Martino V; Gianni W; Pepe J; Minisola S; Malaspina P
Endocrine; 2023 Dec; 82(3):646-653. PubMed ID: 37651007
[TBL] [Abstract][Full Text] [Related]
12. Normocalcaemic primary hyperparathyroidism: what is the role of parathyroid surgery?
Aojula N; Khan S; Gittoes N; Hassan-Smith Z
Ther Adv Endocrinol Metab; 2021; 12():2042018821995370. PubMed ID: 33717430
[TBL] [Abstract][Full Text] [Related]
13. New parathyroid function index for the differentiation of primary and secondary hyperparathyroidism: a case-control study.
Guo Y; Wang Q; Lu C; Fan P; Li J; Luo X; Chen D
BMC Endocr Disord; 2020 Jan; 20(1):5. PubMed ID: 31914999
[TBL] [Abstract][Full Text] [Related]
14. The Ca∗Cl/P Ratio: A Novel and More Appropriate Screening Tool for Normocalcaemic or Overt Primary Hyperparathyroidism.
Yu Y; Qiu J; Chuan F; Feng Z; Long J; Zhou B
Endocr Pract; 2024 Mar; 30(3):231-238. PubMed ID: 38086525
[TBL] [Abstract][Full Text] [Related]
15. LOW FREE (BUT NOT TOTAL) 25-HYDROXYVITAMIN D LEVELS IN SUBJECTS WITH NORMOCALCEMIC HYPERPARATHYROIDISM.
Wang X; Meng L; Su C; Shapses SA
Endocr Pract; 2020 Feb; 26(2):174-178. PubMed ID: 31557077
[No Abstract] [Full Text] [Related]
16. Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism.
Cesareo R; Di Stasio E; Vescini F; Campagna G; Cianni R; Pasqualini V; Romitelli F; Grimaldi F; Manfrini S; Palermo A
Osteoporos Int; 2015 Apr; 26(4):1295-302. PubMed ID: 25524023
[TBL] [Abstract][Full Text] [Related]
17. The value of parathyroid scintigraphy on lesion detection in patients with normocalcemic primary hyperparathyroidism.
Gungor S; Dede F; Can B; Keskin H; Aras M; Ones T; Erdil TY; Turoglu HT
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(2):86-90. PubMed ID: 35292143
[TBL] [Abstract][Full Text] [Related]
18. Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism.
Beysel S; Caliskan M; Kizilgul M; Apaydin M; Kan S; Ozbek M; Cakal E
BMC Cardiovasc Disord; 2019 May; 19(1):106. PubMed ID: 31068134
[TBL] [Abstract][Full Text] [Related]
19. The Eucalcemic Patient With Elevated Parathyroid Hormone Levels.
Shaker JL; Wermers RA
J Endocr Soc; 2023 Feb; 7(4):bvad013. PubMed ID: 36793479
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of coronary calcium score in patients with normocalcemic primary hyperparathyroidism.
Mesquita PN; Dornelas Leão Leite AP; Chagas Crisóstomo SD; Veras Filho E; da Cunha Xavier L; Bandeira F
Vasc Health Risk Manag; 2017; 13():225-229. PubMed ID: 28790836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
